Evidence map›Paper›PMID 26319711›Full record

ArticleJournal of biochemistry2016

Structural basis of Cu, Zn-superoxide dismutase amyloid fibril formation involves interaction of multiple peptide core regions.

Masataka Ida, Mizuho Ando, Masayuki Adachi, Asumi Tanaka, Kodai Machida, Kunihiro Hongo, Tomohiro Mizobata, Miho Yoshida Yamakawa, Yasuhiro Watanabe, Kenji Nakashima and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Masataka IdaDepartment of Chemistry and Biotechnology, Graduate School of Engineering.
Mizuho AndoDepartment of Chemistry and Biotechnology, Graduate School of Engineering.
Masayuki AdachiDepartment of Chemistry and Biotechnology, Graduate School of Engineering.
Asumi TanakaDepartment of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science and.
Kodai MachidaDepartment of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science and.
Kunihiro HongoDepartment of Chemistry and Biotechnology, Graduate School of Engineering, Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science and.
Tomohiro MizobataDepartment of Chemistry and Biotechnology, Graduate School of Engineering, Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science and.
Miho Yoshida YamakawaDivision of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Tottori, Japan.
Yasuhiro WatanabeDivision of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Tottori, Japan.
Kenji NakashimaDivision of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Tottori, Japan.
Yasushi KawataDepartment of Chemistry and Biotechnology, Graduate School of Engineering, Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science and kawata@bio.tottori-u.ac.jp.
Regenerative Medicine Institute · MXTottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cu, Zn-superoxide dismutase (SOD1), an enzyme implicated in the progression of familial amyotrophic lateral sclerosis (fALS), forms amyloid fibrils under certain experimental conditions. As part of our efforts to understand ALS pathogenesis, in this study we found that reduction of the intramolecular disulfide bond destabilized the tertiary structure of metal free wild-type SOD1 and greatly enhanced fibril formation in vitro. We also identified fibril core peptides that are resistant to protease digestion by using mass spectroscopy and Edman degradation analyses. Three regions dispersed throughout the sequence were detected as fibril core sequences of SOD1. Interestingly, by using three synthetic peptides that correspond to these identified regions, we determined that each region was capable of fibril formation, either alone or in a mixture containing multiple peptides. It was also revealed that by reducing the disulfide bond and causing a decrease in the structural stability, the amyloid fibril formation of a familial mutant SOD1 G93A was accelerated even under physiological conditions. These results demonstrate that by destabilizing the structure of SOD1 by removing metal ions and breaking the intramolecular disulfide bridge, multiple fibril-forming core regions are exposed, which then interact with each another and form amyloid fibrils under physiological conditions.

Indexed as

Amino Acid SequenceAmyloidAmyotrophic Lateral SclerosisHumansMicroscopy, Electron, TransmissionMolecular Sequence DataMutationOxidation-ReductionPeptidesProtein Structure, TertiarySuperoxide DismutaseSuperoxide Dismutase-1AmyloidPeptidesSOD1 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1ALSamyloid fibril coremechanismSOD1G93A mutantstructural stability

Identifiers

PMID26319711
PMCPMC4948195
OpenAlexW1865863333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.